Sylvamo Sells a Continent for a 20% Tail — and Buys Itself a Fourth Sheeter

A $1.6B paper maker exits Europe, reverses course on converting, and lets its poison pill lapse — while the lean-transformation story quietly goes missing

SLVM · Earnings Call · 2026-11-06

One continent, sold for a tail

For four straight quarters, John Van Sims defended Sylvamo's European mills as “a bet on the future” — John Sims, Chief Executive Officer · 2026-05-08 — a bet that a fragmented, sub-cost-of-capital market would eventually consolidate into something worth owning. On November 6 he stopped betting. Sylvamo entered a put option agreement with Midas Atlantic Partners, in partnership with the Najafi Companies, for a binding offer on the entire business: the Saillat mill in France, Nymölla in Sweden, and the forestry and commercial operations around them. The Europe business is now the company's single loudest theme — and it is a theme about subtraction.

At closing, we will transfer our Europe business... In exchange, for the Europe business, Sylvamo will receive a right to 20% of any future distributions.
John Van Sims, Chief Executive Officer · 2026-11-06

The proposed sale hands over roughly €50 million of working capital and €35 million of net cash and takes back no equity, no votes, and no board seat — just a economic interest in distributions, joint-venture proceeds, or a future sale, structured as indefinite, non-dilutable, and crucially free of cash calls. George Staphos of Bank of America spent two questions on the mechanics, and Van Sims was unusually explicit: “we have no equity ownership. We have no you know, voting position... It is also indefinite... But you do not have a cash call as well.” — John Van Sims, Chief Executive Officer · 2026-11-06 That is a clean severance, not a partnership. And it answers a question management had been deferring since last summer, when Van Sims said Europe needed "somewhere between $50 million or so" of improvement to clear its cost of capital and that “probably in 2027 we'll make the call” — John Sims, Chief Executive Officer · 2026-08-07 on other options. They made the call early instead.

A doubling that wasn't demand

Third-quarter adjusted EBITDA nearly doubled to $128 million from $66 million, a 20% margin, with adjusted operating earnings of $1.33 a share and free cash flow of $16 million — a $32 million sequential improvement. Read the bridge, though, and the doubling is mostly arithmetic: $38 million came from having no planned maintenance outages in the quarter, and $25 million from paper price and mix. Volume was flat; input and transportation costs were $6 million unfavorable and are guided to be another $6 million worse in the fourth quarter. The filed numbers — which still stop at the July quarter-end, before this print — show why the market had been skeptical. Revenue was $806 million in the July quarter, up 2% year over year but still 13% below the 2022 high, while operating margin sat at just 1.7% and net income was negative $11 million. Capital spending was $61 million, up 296% over a year, pushing free cash flow to negative $26 million and leaving an effective net debt position of $656 million. Interest coverage of 0.9x is the number that explains why the buyback has been zero for two straight quarters.

The sheeter that became a strategy

Buried behind the Europe headline is a genuine reversal. Sylvamo had planned to replace one of three sheeters at its Sumter, South Carolina converting plant. It now keeps two and adds a fourth — 500,000 tons of annual cut-size capacity, 200,000 more than today — for about $25 million of extra 2027 CapEx and a startup pushed to early in the third quarter next year. The trigger is tariffs: cut-size from Brazil is “no longer economically viable due to tariff changes” — John Van Sims, Chief Executive Officer · 2026-11-06, and rather than route those tons through expensive outside converting, management is internalizing them. The fourth sheeter is now a top-five company keyword, alongside incremental converting — a phrase that did not exist in this story a quarter ago. It comes with a cost that undercuts an earlier promise. The incremental converting expense management had framed as a 2026 one-time does not roll off:

that what we originally thought was a onetime would not go away. So incremental converting in 2027 approximately $20 million.
Donald Paul Devlin, Senior Vice President and Chief Financial Officer · 2026-11-06

Add distribution cost — management says costs are up roughly $50 million from 2025 into 2027, mostly distribution — and the cost story that was supposed to be resolving is instead compounding. The offset is the Eastover outage, an extended ~50-day shutdown underway now that removes about 7% of North American industry supply and carries a $25 million non-repeat charge into next year, plus the paper-machine optimization that is 60% complete, on schedule and on budget, adding 60,000 tons as it ramps.

What went quiet

The lean transformation — the CEO's signature initiative from his January shareholder letter, two quarters ago the number-one keyword on these calls, pitched as doubling the historical rate of improvement — now appears as a single line: roughly $15 million of identified annualized benefit. The investor day he promised has been pushed to "sometime second, third quarter" of next year. And the $300 million free cash flow target has become a promissory note: “we are going to share more about the long term potential of our stronger Sylvamo at the appropriate time once we complete the proposed sale of the European business.” — John Van Sims, Chief Executive Officer · 2026-11-06 Meanwhile the language on Europe has flipped entirely. In May, Van Sims said “as of today, we believe we have the right strategy in Europe, the right leadership team, and strong customer relationships.” — John Sims, Chief Executive Officer · 2026-05-08 Six months later the right strategy is a buyer.

The tape, the pill, and the gap

The stock tells its own version. SLVM is up 57.5% since its 2021 spinoff but sits 58.8% below the November 2024 peak of $95.69, and has been flat over the last ninety sessions — except for a 24% surge in the final three days into this print, an unusual amount of pre-announcement conviction for a small-cap paper name. At 0.5x revenue, the market has already priced a shrinking, lower-margin business. What it has not priced is optionality — which makes the governance news notable. The shareholder rights plan adopted last November expires Monday, November 9, and will not be renewed: “the shareholder rights plan that they board adopted last November does expire this Monday, November 9, and our board has decided to let this plan expire.” — John Van Sims, Chief Executive Officer · 2026-11-06 That is a change in posture from August, when the answer was “the board hasn't made a decision yet.” — John Sims, Chief Executive Officer · 2026-08-07 With Atlas Holdings as anchor shareholder and management having said in May that “our share price does not reflect the intrinsic value of the company,” — John Sims, Chief Executive Officer · 2026-05-08 a lapsed pill on top of a completed European exit turns Sylvamo into a smaller, simpler, Americas-only target — exactly the kind of asset a strategic or a controlling holder can underwrite. The open questions are concrete: the works council consultation and a close by the end of the first quarter of 2027; whether the 20% tail ever distributes anything; whether the fourth sheeter lands before the next tariff revision; and whether a company that just told investors to wait for the "appropriate time" on capital allocation keeps waiting.